|
2023-08-11 |
2023-08-01 |
S
Venta
|
Chief Executive Officer
Oficial
|
37 721
-30.4%
486,78
4.655.205 US$
|
37 721
-30.4%
|
486,78
|
4.655.205 US$
|
|
|
2023-08-11 |
2023-08-01 |
S
Venta
|
Deputy GC
Oficial
|
1 586
-27.5%
95,06
1.395.353 US$
|
1 586
-27.5%
|
95,06
|
1.395.353 US$
|
|
|
2023-08-11 |
2023-08-01 |
S
Venta
|
Chief Medical Officer
Oficial
|
41 295
+18.2%
413,46
1.973.319 US$
|
41 295
+18.2%
|
413,46
|
1.973.319 US$
|
|
|
2023-08-11 |
2023-08-01 |
S
Venta
|
Chief Financial Officer
Oficial
|
9 434
-8.5%
0,94
8.868 US$
|
9 434
-8.5%
|
0,94
|
8.868 US$
|
|
|
2022-08-05 |
2022-08-03 |
S
Venta
|
Chief Scientific Officer
Oficial
|
4 463
-4.9%
1,72
7.676 US$
|
4 463
-4.9%
|
1,72
|
7.676 US$
|
|
|
2022-08-05 |
2022-08-03 |
S
Venta
|
Chief Financial Officer
Oficial
|
5 980
-5.1%
1,72
10.286 US$
|
5 980
-5.1%
|
1,72
|
10.286 US$
|
|
|
2022-08-05 |
2022-08-03 |
S
Venta
|
Chief Medical Officer
Oficial
|
4 463
-6.5%
1,72
7.676 US$
|
4 463
-6.5%
|
1,72
|
7.676 US$
|
|
|
2022-08-05 |
2022-08-03 |
S
Venta
|
Chief Executive Officer
Oficial
|
10 594
-9.6%
1,72
18.222 US$
|
10 594
-9.6%
|
1,72
|
18.222 US$
|
|
|
2022-08-05 |
2022-08-03 |
S
Venta
|
Chief Business Officer
Oficial
|
5 676
-14.9%
1,72
9.763 US$
|
5 676
-14.9%
|
1,72
|
9.763 US$
|
|
|
2022-01-14 |
2021-07-21 |
S
Venta
|
Chief Medical Officer
Oficial
|
14 809
-32.9%
6,10
90.335 US$
|
14 809
-32.9%
|
6,10
|
90.335 US$
|
|
|
2022-01-14 |
2021-07-21 |
S
Venta
|
Chief Scientific Officer
Oficial
|
26 325
-32.9%
6,10
160.582 US$
|
26 325
-32.9%
|
6,10
|
160.582 US$
|
|
|
2022-01-14 |
2021-07-21 |
S
Venta
|
Chief Executive Officer
Oficial
|
33 500
-38.1%
6,10
204.350 US$
|
33 500
-38.1%
|
6,10
|
204.350 US$
|
|
|
2022-01-14 |
2021-07-21 |
S
Venta
|
Consejero no ejecutivo
|
127 778
-49.7%
6,10
779.446 US$
|
127 778
-49.7%
|
6,10
|
779.446 US$
|
|
|
2022-01-14 |
2021-07-21 |
S
Venta
|
Chief Financial Officer
Oficial
|
19 854
-20.0%
6,10
121.109 US$
|
19 854
-20.0%
|
6,10
|
121.109 US$
|
|
|
2022-01-14 |
2021-07-21 |
S
Venta
|
Chief Legal Officer
Oficial
|
26 325
-32.9%
6,10
160.582 US$
|
26 325
-32.9%
|
6,10
|
160.582 US$
|
|
|
2021-06-11 |
2021-06-11 |
S
Venta
|
Consejero no ejecutivo
|
15 273
-5.6%
7,61
116.226 US$
|
15 273
-5.6%
|
7,61
|
116.226 US$
|
|
|
2021-06-11 |
2021-06-10 |
S
Venta
|
Consejero no ejecutivo
|
234 727
-47.3%
7,66
1.798.619 US$
|
234 727
-47.3%
|
7,66
|
1.798.619 US$
|
|
|
2021-02-18 |
2021-02-16 |
Por favor
Venta prevista
|
Chief Medical Officer
Oficial
|
1 000
-1.1%
11,35
11.350 US$
|
1 000
-1.1%
|
11,35
|
11.350 US$
|
|
|
2021-02-09 |
2021-02-08 |
Por favor
Venta prevista
|
Chief Executive Officer
Consejero ejecutivo
|
2 500
-0.9%
12,50
31.250 US$
|
2 500
-0.9%
|
12,50
|
31.250 US$
|
|
|
2021-02-09 |
2021-02-08 |
Por favor
Venta prevista
|
See Remarks
Oficial
|
1 500
-1.5%
12,45
18.675 US$
|
1 500
-1.5%
|
12,45
|
18.675 US$
|
|
|
2021-02-03 |
2021-02-01 |
Por favor
Venta prevista
|
Chief Executive Officer
Consejero ejecutivo
|
2 500
-0.9%
10,69
26.718 US$
|
2 500
-0.9%
|
10,69
|
26.718 US$
|
|
|
2021-02-03 |
2021-02-01 |
Por favor
Venta prevista
|
See Remarks
Oficial
|
1 500
-1.5%
11,19
16.785 US$
|
1 500
-1.5%
|
11,19
|
16.785 US$
|
|
|
2021-01-21 |
2021-01-19 |
Por favor
Venta prevista
|
Chief Executive Officer
Consejero ejecutivo
|
5 000
-1.9%
13,00
65.000 US$
|
5 000
-1.9%
|
13,00
|
65.000 US$
|
|
|
2021-01-15 |
2021-01-15 |
Por favor
Venta prevista
|
Chief Medical Officer
Oficial
|
2 000
-2.2%
12,25
24.500 US$
|
2 000
-2.2%
|
12,25
|
24.500 US$
|
|
|
2021-01-15 |
2021-01-14 |
Por favor
Venta prevista
|
Chief Medical Officer
Oficial
|
7 000
-7.1%
11,95
83.650 US$
|
7 000
-7.1%
|
11,95
|
83.650 US$
|
|
|
2020-12-21 |
2020-12-17 |
S
Venta
|
Consejero no ejecutivo
|
1 700 000
-36.6%
18,10
30.770.000 US$
|
1 700 000
-36.6%
|
18,10
|
30.770.000 US$
|
|
|
2020-12-21 |
2020-12-17 |
S
Venta
|
Gran accionista
|
1 700 000
-36.6%
18,10
30.770.000 US$
|
1 700 000
-36.6%
|
18,10
|
30.770.000 US$
|
|
|
2020-12-17 |
2020-12-15 |
Por favor
Venta prevista
|
Chief Medical Officer
Oficial
|
1 000
-1.0%
10,48
10.480 US$
|
1 000
-1.0%
|
10,48
|
10.480 US$
|
|
|
2020-12-15 |
2020-12-11 |
Por favor
Venta prevista
|
Chief Medical Officer
Oficial
|
1 405
-1.4%
10,05
14.120 US$
|
1 405
-1.4%
|
10,05
|
14.120 US$
|
|
|
2020-11-13 |
2020-11-11 |
Por favor
Venta prevista
|
Chief Medical Officer
Oficial
|
595
-0.6%
10,05
5.980 US$
|
595
-0.6%
|
10,05
|
5.980 US$
|
|
|
2020-10-16 |
2020-10-14 |
Por favor
Venta prevista
|
Chief Medical Officer
Oficial
|
4 000
-3.8%
10,05
40.200 US$
|
4 000
-3.8%
|
10,05
|
40.200 US$
|
|
|
2020-09-03 |
2020-09-01 |
S
Venta
|
Gran accionista
|
332 780
-6.6%
7,14
2.376.681 US$
|
332 780
-6.6%
|
7,14
|
2.376.681 US$
|
|
|
2020-05-22 |
2020-05-20 |
S
Venta
|
Gran accionista
|
420 000
-12.7%
3,66
1.535.562 US$
|
420 000
-12.7%
|
3,66
|
1.535.562 US$
|
|
|
2020-02-07 |
2020-02-05 |
B
Compra
|
Chief Executive Officer
Consejero ejecutivo
|
5 000
+1.9%
3,23
16.150 US$
|
5 000
+1.9%
|
3,23
|
16.150 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
Atlas Venture Fund IX, L.P.
Gran accionista
|
100 000
+2.2%
15,00
1.500.000 US$
|
100 000
+2.2%
|
15,00
|
1.500.000 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
Viswanathan Ravi
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
Sonsini Peter W.
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
Florence Anthony A. Jr.
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
GRAYZEL DAVID S.
Consejero no ejecutivo
|
100 000
+2.2%
15,00
1.500.000 US$
|
100 000
+2.2%
|
15,00
|
1.500.000 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
New Enterprise Associates 14, L.P.
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
LV Management Group, LLC
Gran accionista
|
266 000
+8.4%
15,00
3.990.000 US$
|
266 000
+8.4%
|
15,00
|
3.990.000 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
Shanafelt Armen
Consejero no ejecutivo
Gran accionista
|
266 000
+8.4%
15,00
3.990.000 US$
|
266 000
+8.4%
|
15,00
|
3.990.000 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
BARRIS PETER J
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
BARRETT M JAMES
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
Novartis Institutes for BioMedical Research, Inc.
Gran accionista
|
766 666
+24.1%
15,00
11.499.990 US$
|
766 666
+24.1%
|
15,00
|
11.499.990 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
KERINS PATRICK J
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
SANDELL SCOTT D
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
MOTT DAVID M
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|
|
2018-04-23 |
2018-04-23 |
B
Compra
|
BASKETT FOREST
Gran accionista
|
133 333
+4.2%
15,00
1.999.995 US$
|
133 333
+4.2%
|
15,00
|
1.999.995 US$
|
|